GO
Loading...

CNBC's Huckman: More Questions Arise on Drug-Coated Stents

Two studies and an editorial in the journal of the American Medical Association are raising even more questions about the safety of drug-coated stents and could further hurt already-declining sales.

This concerns so-called "off-label" use of drug-coated stents, which actually makes up the majority of procedures. It involves people who are in the throes of a heart attack, have big, multiple blockages or other medical complications.

Researchers say after one year, those patients had double the risk of death versus those who were treated "on-label" or have just one blocked artery.

And one of the studies says it only saw that problem with Boston Scientific's stent and not Johnson & Johnson's, though J&J paid for that study.

The JAMA editorial says doctors shouldn't "succumb to the hope and hype" of drug-coated stents. In fact safety issues and other new studies have led more doctors to switch back to bare metal stents or old-fashioned heart drugs.

J&J and Boston Scientific make the only drug-coated stents on the U.S. market. But Medtronic and Abbott hope to come to market here soon.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • John Kerry meets with Iran foreign minister to discuss nuclear agreement; Vladimir Putin speaks on Boris Nimstov shooting; and Staples needs to improve its board, reports CNBC's Sue Herera.

  • The Supreme Court is hearing arguments in the health care case King v. Burwell. Insight to Justice Kennedy's remarks, and health care stocks on the move, with CNBC's Hampton Pearson.

  • The Supreme Court is hearing arguments in the health care case King v. Burwell over whether the Affordable Care Act should allow the IRS to provide tax credits to individuals who purchase health insurance on a Federal exchange.